advertisement
11.14 Investigational drugs; pharmacological experiments (23)
Showing records 1 to 23
Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments
Search within classification 11.14 Investigational drugs; pharmacological experiments58916 Effect of the Aβ aggregation modulator MRZ-99030 on retinal damage in an animal model of glaucoma
Salt TE; Nizari S; Cordeiro MF; Russ H; Danysz W
Neurotoxicity research 2014; 26: 440-446
58772 Renin-angiotensin system regulates neurodegeneration in a mouse model of normal tension glaucoma
Semba K; Namekata K; Guo X; Harada C; Harada T; Mitamura Y
Cell Death and Disease 2014; 5: e1333
58506 Effects of K-115, a rho-kinase inhibitor, on aqueous humor dynamics in rabbits
Isobe T; Mizuno K; Kaneko Y; Ohta M; Koide T; Tanabe S
Current Eye Research 2014; 39: 813-822
58860 Effects of coenzyme Q10 in conjunction with vitamin E on retinal-evoked and cortical-evoked responses in patients with open-angle glaucoma
Parisi V; Centofanti M; Gandolfi S; Marangoni D; Rossetti L; Tanga L; Tardini M; Traina S; Ungaro N; Vetrugno M; Falsini B
Journal of Glaucoma 2014; 23: 391-404
59314 Tissue plasminogen activator reduces the elevated intraocular pressure induced by prednisolone in sheep
Candia OA; Gerometta RM; Danias J
Experimental Eye Research 2014; 128: 114-116
59438 Neuroprotective and neurite outgrowth effects of maltol on retinal ganglion cells under oxidative stress
Hong S; Iizuka Y; Lee T; Kim CY; Seong GJ
Molecular Vision 2014; 20: 1456-1462
59266 The Novel Rho Kinase (ROCK) Inhibitor K-115: A New Candidate Drug for Neuroprotective Treatment in Glaucoma
Yamamoto K; Maruyama K; Himori N; Omodaka K; Yokoyama Y; Shiga Y; Morin R; Nakazawa T
Investigative Ophthalmology and Visual Science 2014; 55: 7126-7136
59294 Neuroprotection of a novel cyclopeptide C*HSDGIC* from the cyclization of PACAP (1-5) in cellular and rodent models of retinal ganglion cell apoptosis
Cheng H; Ding Y; Yu R; Chen J; Wu C
PLoS ONE 2014; 9: e108090
58505 Nerve growth factor modulation of retinal ganglion cell physiology
Roberti G; Mantelli F; Macchi I; Massaro-Giordano M; Centofanti M
Journal of Cellular Physiology 2014; 229: 1130-1133
59530 Neurosteroids are endogenous neuroprotectants in an ex vivo glaucoma model
Ishikawa M; Yoshitomi T; Zorumski CF; Izumi Y
Investigative Ophthalmology and Visual Science 2014; 0:
59535 Tumor necrosis factor alpha has an early protective effect on retinal ganglion cells after optic nerve crush
Mac Nair CE; Fernandes KA; Schlamp CL; Libby RT; Nickells RW
Journal of Neuroinflammation 2014; 11: 194
59389 Effect of Eye Drops Containing Disulfiram and Low-Substituted Methylcellulose in Reducing Intraocular Pressure in Rabbit Models
Nagai N; Yoshioka C; Mano Y; Ito Y; Okamoto N; Shimomura Y
Current Eye Research 2014; 0: 1-11
58752 Dock GEFs and their therapeutic potential: neuroprotection and axon regeneration
Namekata K; Kimura A; Kawamura K; Harada C; Harada T
Progress in Retinal and Eye Research 2014; 43: 1-16
59231 Double-masked, Randomized, Dose-Response Study of AR-13324 versus Latanoprost in Patients with Elevated Intraocular Pressure
Bacharach J; Dubiner HB; Levy B; Kopczynski CC; Novack GD;
Ophthalmology 2015; 122: 302-307
59385 Hybrid formulations of liposomes and bioadhesive polymers improve the hypotensive effect of the melatonin analogue 5-MCA-NAT in rabbit eyes
Quinteros D; Vicario-de-la-Torre M; Andrés-Guerrero V; Palma S; Allemandi D; Herrero-Vanrell R; Molina-Martínez IT
PLoS ONE 2014; 9: e110344
59157 Latrunculin B Reduces Intraocular Pressure in Human Ocular Hypertension and Primary Open-Angle Glaucoma
Rasmussen CA; Kaufman PL; Ritch R; Haque R; Brazzell RK; Vittitow JL
Translational vision science & technology 2014; 3: 1
59332 Application of Retinalamin for the treatment of glaucomatous optic neuropathy
Makashova NV; Vasil'eva AE; Morozova NE; Ronzina IA
Vestnik Oftalmologii 2014; 130: 71-76, 78-80
59443 A Class of 4-Sulfamoylphenyl-ω-aminoalkyl Ethers with Effective Carbonic Anhydrase Inhibitory Action and Antiglaucoma Effects
Bozdag M; Pinard M; Carta F; Masini E; Scozzafava A; McKenna R; Supuran CT
Journal of Medicinal Chemistry 2014; 57: 9673-9686
59343 Conjunctival matrix metalloproteinases and their inhibitors in glaucoma patients
Helin-Toiviainen M; Rönkkö S; Puustjärvi T; Rekonen P; Ollikainen M; Uusitalo H
Acta Ophthalmologica 2015; 93: 165-171
59335 Preclinical pharmacology, ocular tolerability and ocular hypotensive efficacy of a novel non-peptide bradykinin mimetic small molecule
Sharif NA; Li L; Katoli P; Xu S; Veltman J; Li B; Scott D; Wax M; Gallar J; Acosta C; Belmonte C
Experimental Eye Research 2014; 128: 170-180
59536 Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
Giacoppo S; Mandolino G; Galuppo M; Bramanti P; Mazzon E
Molecules 2014; 19: 18781-18816
58815 Reduction of conjunctival fibrosis after trabeculectomy using topical α-lipoic acid in rabbit eyes
Ekinci M; Cagatay HH; Ceylan E; Keles S; Koban Y; Gokce G; Huseyinoğlu U; Ozcan E; Oba ME
Journal of Glaucoma 2014; 23: 372-379
59364 The ocular hypotensive effect of saffron extract in primary open angle glaucoma: a pilot study
Jabbarpoor Bonyadi MH; Yazdani S; Saadat S
BMC complementary and alternative medicine 2014; 14: 399